Clinical outcome of febrile neutropenia in children with cancer using ceftazidime and aminoglycosides

被引：10
|
作者：
Laoprasopwattana, Kamolwish [1 ]
Pruekprasert, Pornpirnol [1 ]
Laosombat, Vichai [1 ]
Wongchanchailert, Malai [1 ]
机构：
[1] Prince Songkla Univ, Fac Med, Dept Pediat, Hat Yai 90110, Thailand
来源：
PEDIATRIC HEMATOLOGY AND ONCOLOGY | 2007年 / 24卷 / 5-8期
关键词：
aminoglycosides; ceftazidime; children; lever; neutropenia;
D O I：
10.1080/08880010701703636
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
To determine treatment outcome using ceftazidime-aminoglycosides in febrile neutropenic children with cancer, the authors conducted a prospective cohort study in 216 episodes. Early and complete responses to antibiotics were 108/216 (50.0%) and 133/216 (61.6%) episodes, respectively. Death, a modification of antibiotic(s), and resistance to ceftazidime were 2/118 (1.7%), 73/216 (33.8%), and 4/216 (1.9%) episodes, respectively. Primary bacteremia and emerging bacteremia during treatment were 20/216 (9.3%) and 5/216 (2.3%) episodes. Ceftazidime-aminoglycosides was found to be a reasonable initial treatment of febrile neutropenia in the authors' institution. Imipenem is considered in patients who have clinical sepsis and who fail to respond to initial treatment.
引用
收藏
页码：595 / 606
页数：12
相关论文
共 50 条
  • [31] Clinical Impact of Isolating Respiratory Viruses in Children with Febrile Neutropenia
    Jain, P.
    Gunasekaran, V.
    Dinand, V.
    Radhakrishnan, N.
    Sachdeva, A.
    [J]. PEDIATRIC BLOOD & CANCER, 2017, 64 : S63 - S63
  • [32] CEFTAZIDIME VERSUS CEFTAZIDIME PLUS TOBRAMYCIN IN FEBRILE NEUTROPENIC CHILDREN
    JACOBS, RF
    VATS, TS
    PAPPA, KA
    CHAUDHARY, S
    KLETZEL, M
    BECTON, DL
    [J]. INFECTION, 1993, 21 (04) : 223 - 228
  • [33] POST CHEMOTHERAPY FEBRILE NEUTROPENIA IN HEMATOLOGIC MALIGNANCIES: CLINICAL CHARACTERISTICS AND OUTCOME
    Syrigou, A.
    Iskas, M.
    Antoniou, A.
    Marvaki, N.
    Baliakas, P.
    Papadopoulos, V.
    Kelaidi, C.
    Lalayanni, C.
    Saloum, R.
    Sotiropoulos, D.
    Anagnostopoulos, A.
    [J]. HAEMATOLOGICA, 2012, 97 : 572 - 573
  • [34] Coronaviruses in children with febrile neutropenia
    Alvares, Paula A.
    Berezin, Eitan N.
    Botelho, Andrea C.
    Tiemi, Denise
    Spinardi, Julia R.
    Maruyama, Claudia
    Bruniera, Paula
    Passos, Saulo D.
    Mimica, Marcelo J.
    [J]. BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2014, 18 (01): : 98 - 99
  • [35] Bacteraemia in children with febrile neutropenia
    Singh, Y.
    Rastogi, G. C.
    Russell, K.
    Waghorn, D.
    [J]. ACTA PAEDIATRICA, 2007, 96 : 219 - 220
  • [36] Nephrotoxicity of different aminoglycosides during febrile neutropenia caused by cisplatin chemotherapy
    Milovic, Marijana M.
    Radosevic-Jelic, Ljiljana
    Jelic, Svetislav
    [J]. ANNALS OF ONCOLOGY, 2007, 18 : 195 - 195
  • [37] Sepsis in Children with Febrile Neutropenia
    Mongkolrattanothai, Kanokporn
    Bard, Jennifer Dien
    [J]. JOURNAL OF APPLIED LABORATORY MEDICINE, 2019, 3 (04): : 530 - 533
  • [38] Continuous infusion of ceftazidime in the empiric treatment of febrile neutropenic children with cancer
    Dalle, JH
    Gnansounou, M
    Husson, MO
    Lambilliotte, A
    Mazingue, F
    Nelken, B
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2002, 24 (09) : 714 - 716
  • [39] Cefepime versus ceftazidime as empiric monotherapy for fever and neutropenia in children with cancer
    Chuang, YY
    Hung, IJ
    Yang, CP
    Jaing, TH
    Lin, TY
    Huang, YC
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2002, 21 (03) : 203 - 209
  • [40] Febrile neutropenia in children with cancer; a retrospective Norwegian multicentre study
    Stabell, N.
    Nordal, E.
    Wiger, K.
    Lund, B.
    Stensvold, E.
    Taxt, A.
    Buhring, F.
    Greve-Isdahl, M.
    Fornebo, H.
    Simonsen, G.
    Klingenberg, C.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S174 - S174
12345